Medytox Inc.

Medytox is a South Korean biopharmaceutical company specializing in the development, manufacture, and marketing of botulinum toxin products, hyaluronic acid fillers, and medical devices. Founded in 2000, the company has established itself as a significant player in the global medical aesthetics market, with a portfolio that includes flagship neuromodulators such as Neuronox, Innotox, and Coretox. The company operates with a strong focus on R&D, investing a significant portion of its revenue into the development of innovative biopharmaceuticals, including treatments for therapeutic indications beyond aesthetics. Medytox maintains a global presence through various joint ventures and subsidiaries, including its North American subsidiary, Luvantas, as it seeks to expand its footprint in the United States and other international markets.